{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:55:29Z","timestamp":1788461729993,"version":"build-2803163510"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.molimm.2019.05.011","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T07:59:05Z","timestamp":1559807945000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["An overview of lipodystrophy and the role of the complement system"],"prefix":"10.1016","volume":"112","author":[{"given":"F.","family":"Corvillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Akinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2019.05.011_bib0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000439432","article-title":"Effects of recombinant human leptin (Metreleptin) on nocturnal luteinizing hormone secretion in lipodystrophy patients","volume":"103","author":"Abel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.molimm.2019.05.011_bib0010","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/cen.13311","article-title":"Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort","volume":"86","author":"Ajluni","year":"2017","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0020","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.metabol.2015.06.004","article-title":"Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities","volume":"64","author":"Akinci","year":"2015","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.molimm.2019.05.011_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.molimm.2019.05.011_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11892-018-1100-7","article-title":"Update on therapeutic options in lipodystrophy","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.molimm.2019.05.011_bib0035","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1210\/jc.2016-1005","article-title":"Natural history of congenital generalized lipodystrophy: a nationwide study from Turkey","volume":"101","author":"Akinci","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.metabol.2017.04.010","article-title":"Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy","volume":"72","author":"Akinci","year":"2017","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.molimm.2019.05.011_bib0045","series-title":"Endotext","article-title":"Lipodystrophy syndromes: presentation and treatment","author":"Akinci","year":"2000"},{"key":"10.1016\/j.molimm.2019.05.011_bib0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJM197303222881204","article-title":"Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3","volume":"288","author":"Alper","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.05.011_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12020-014-0450-4","article-title":"Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience","volume":"49","author":"Araujo-Vilar","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.molimm.2019.05.011_bib0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40618-018-0887-z","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar","year":"2019","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.molimm.2019.05.011_bib0065","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI116733","article-title":"The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis","volume":"92","author":"Baldo","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.05.011_bib0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molimm.2015.02.027","article-title":"The role of complement factor C3 in lipid metabolism","volume":"67","author":"Barbu","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12915-015-0203-8","article-title":"Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes","volume":"13","author":"Berends","year":"2015","journal-title":"BMC Biol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0080","doi-asserted-by":"crossref","first-page":"5696815","DOI":"10.1155\/2018\/5696815","article-title":"Adipokines as biomarkers in health and disease","volume":"2018","author":"Bienertova-Vasku","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.molimm.2019.05.011_bib0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2133.2004.06308.x","article-title":"The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2\/C4 deficiency","volume":"152","author":"Boeckler","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0090","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0095","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1172\/JCI95476","article-title":"Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy","volume":"128","author":"Brown","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.05.011_bib0100","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/oby.20175","article-title":"Increased acylation stimulating protein levels in young obese males is correlated with systemic markers of oxidative stress","volume":"21","author":"Celik","year":"2013","journal-title":"Obesity Silver Spring (Silver Spring)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0105","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4158\/EP11229.OR","article-title":"Clinical effects of long-term metreleptin treatment in patients with lipodystrophy","volume":"17","author":"Chan","year":"2011","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.molimm.2019.05.011_bib0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4158\/EP09154.RA","article-title":"Clinical classification and treatment of congenital and acquired lipodystrophy","volume":"16","author":"Chan","year":"2010","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.molimm.2019.05.011_bib0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fendo.2016.00030","article-title":"Adipose tissue remodeling: its role in energy metabolism and metabolic disorders","volume":"7","author":"Choe","year":"2016","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0120","doi-asserted-by":"crossref","first-page":"12736","DOI":"10.1016\/S0021-9258(18)42338-1","article-title":"Adipsin and an endogenous pathway of complement from adipose cells","volume":"267","author":"Choy","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.05.011_bib0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/j.1550-8528.1996.tb00266.x","article-title":"Regulation of alternative pathway activation and C3a production by adipose cells","volume":"4","author":"Choy","year":"1996","journal-title":"Obes. Res."},{"key":"10.1016\/j.molimm.2019.05.011_bib0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2265.2005.02260.x","article-title":"Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children","volume":"62","author":"Cianflone","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0135","doi-asserted-by":"crossref","first-page":"9489","DOI":"10.1021\/bi00198a014","article-title":"Adipsin\/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis","volume":"33","author":"Cianflone","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2019.05.011_bib0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(02)00686-7","article-title":"Critical review of acylation-stimulating protein physiology in humans and rodents","volume":"1609","author":"Cianflone","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molimm.2019.05.011_bib0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0021-9258(17)31275-9","article-title":"Purification and characterization of acylation stimulating protein","volume":"264","author":"Cianflone","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.05.011_bib0150","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.117.09242","article-title":"Complement factor B is a determinant of both metabolic and cardiovascular features of metabolic syndrome","author":"Coan","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.molimm.2019.05.011_bib0155","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2337\/diabetes.51.9.2727","article-title":"Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy","volume":"51","author":"Colombo","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2019.05.011_bib0160","first-page":"731","article-title":"[Familial autoimmune hepatitis and C4 deficiency]","volume":"19","author":"Constans","year":"1998","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.molimm.2019.05.011_bib0165","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1126\/science.3299705","article-title":"Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve","volume":"237","author":"Cook","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.05.011_bib0170","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3389\/fimmu.2018.02142","article-title":"Autoantibodies against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy","volume":"9","author":"Corvillo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nefro.2017.10.002","article-title":"Acquired partial lipodystrophy and C3 glomerulopathy: dysregulation of the complement system as a common pathogenic mechanism","volume":"38","author":"Corvillo","year":"2018","journal-title":"Nefrologia"},{"key":"10.1016\/j.molimm.2019.05.011_bib0180","doi-asserted-by":"crossref","first-page":"E1482","DOI":"10.1152\/ajpendo.00565.2006","article-title":"Acylation-stimulating protein\/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo","volume":"293","author":"Cui","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.123.2.755","article-title":"Further evidence for the antibody nature of C3 nephritic factor (C3NeF)","volume":"123","author":"Daha","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0190","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4049\/jimmunol.120.5.1770.c","article-title":"IgG subclass studies of C3 nephritic factor (C3NeF)","volume":"120","author":"Davis","year":"1978","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0195","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.nefro.2016.03.003","article-title":"Acquired partial lipodystrophy (Barraquer-Simons syndrome) and IgA nephropathy","volume":"36","author":"de Lucas-Collantes","year":"2016","journal-title":"Nefrologia"},{"key":"10.1016\/j.molimm.2019.05.011_bib0200","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","author":"Diker-Cohen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/08916939409009525","article-title":"Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis","volume":"18","author":"Doherty","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1016\/j.molimm.2019.05.011_bib0210","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy","volume":"92","author":"Ebihara","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4274\/jcrpe.v2i1.39","article-title":"Acquired generalized lipodystrophy associated with autoimmune hepatitis and low serum C4 level","volume":"2","author":"Eren","year":"2010","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0220","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0225","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.05.011_bib0230","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","article-title":"Adipokines in health and disease","volume":"36","author":"Fasshauer","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molimm.2019.05.011_bib0235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbrc.2013.06.090","article-title":"Obesity-inducing diet promotes acylation stimulating protein resistance","volume":"437","author":"Fisette","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2019.05.011_bib0240","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.3299706","article-title":"Severely impaired adipsin expression in genetic and acquired obesity","volume":"237","author":"Flier","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.05.011_bib0245","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.05.011_bib0250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ecl.2004.03.003","article-title":"Lipodystrophies: rare disorders causing metabolic syndrome","volume":"33","author":"Garg","year":"2004","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.molimm.2019.05.011_bib0255","first-page":"59","article-title":"Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a\/c gene","volume":"86","author":"Garg","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","article-title":"Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice","volume":"105","author":"Gavrilova","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.05.011_bib0265","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13300-016-0187-6","article-title":"Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear?","volume":"7","author":"Gentile","year":"2016","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.molimm.2019.05.011_bib0270","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0026-0495(93)90215-A","article-title":"Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein","volume":"42","author":"Germinario","year":"1993","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.molimm.2019.05.011_bib0275","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0280","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00281-017-0661-x","article-title":"The properdin pathway: an \u201calternative activation pathway\u201d or a \u201ccritical amplification loop\u201d for C3 and C5 activation?","volume":"40","author":"Harrison","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-0029-1211955","article-title":"Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes","volume":"106","author":"H\u00fcbler","year":"1998","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.molimm.2019.05.011_bib0295","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy syndromes","volume":"45","author":"Hussain","year":"2016","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.molimm.2019.05.011_bib0300","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1210\/jc.2003-032140","article-title":"Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy","volume":"89","author":"Javor","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0305","doi-asserted-by":"crossref","first-page":"11123","DOI":"10.1074\/jbc.M206169200","article-title":"The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77\/acylation-stimulating protein","volume":"278","author":"Kalant","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.05.011_bib0310","doi-asserted-by":"crossref","first-page":"23936","DOI":"10.1074\/jbc.M406921200","article-title":"C5L2 is a functional receptor for acylation-stimulating protein","volume":"280","author":"Kalant","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.05.011_bib0315","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2019-00200","article-title":"Effects of metreleptin on proteinuria in patients with lipodystrophy","author":"Lee","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0320","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2230.2000.00717.x","article-title":"Partial lipodystrophy and renal disease","volume":"25","author":"Lenane","year":"2000","journal-title":"Clin. Exp. Dermatol."},{"issue":"Suppl. 1","key":"10.1016\/j.molimm.2019.05.011_bib0325","first-page":"6","article-title":"Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy","volume":"5","author":"Levandoski","year":"1982","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molimm.2019.05.011_bib0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2017.02.018","article-title":"C3 nephritic factors: a changing landscape","volume":"140","author":"Levy Erez","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0335","doi-asserted-by":"crossref","first-page":"42628","DOI":"10.1038\/srep42628","article-title":"Association between C4, C4A, and C4B copy number variations and susceptibility to autoimmune diseases: a meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2019.05.011_bib0340","doi-asserted-by":"crossref","first-page":"e0199052","DOI":"10.1371\/journal.pone.0199052","article-title":"Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy","volume":"13","author":"Lima","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.05.011_bib0345","first-page":"1489","article-title":"Immunological abnormalities in autoimmune chronic active hepatitis","volume":"16","author":"Lin","year":"1989","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.0954-6820.1974.tb08177.x","article-title":"Partial lipodystrophy and chronic hypocomplementemic glomerulonephritis","volume":"195","author":"Ljunghall","year":"1974","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.molimm.2019.05.011_bib0355","article-title":"Complement as a diagnostic tool in immunopathology","author":"L\u00f3pez-Lera","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0360","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jc.2011-1896","article-title":"Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome","volume":"97","author":"Lungu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0365","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1194\/jlr.M500500-JLR200","article-title":"Targeting the signaling pathway of acylation stimulating protein","volume":"47","author":"Maslowska","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molimm.2019.05.011_bib0370","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2362.1999.00514.x","article-title":"Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations","volume":"29","author":"Maslowska","year":"1999","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.05.011_bib0375","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.177.6.1827","article-title":"Complement-mediated adipocyte lysis by nephritic factor sera","volume":"177","author":"Mathieson","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2019.05.011_bib0380","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bbrc.2017.11.069","article-title":"Adipose tissue complement factor B promotes adipocyte maturation","volume":"495","author":"Matsunaga","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2019.05.011_bib0385","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00005-013-0229-y","article-title":"Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication","volume":"61","author":"Matsushita","year":"2013","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.molimm.2019.05.011_bib0390","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1210\/jc.2003-031868","article-title":"Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency","volume":"89","author":"McDuffie","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0395","first-page":"6","article-title":"Complement system part I \u2013 molecular mechanisms of activation and regulation","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0405","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1093\/nar\/14.22.8879","article-title":"Adipsin, the adipocyte serine protease: gene structure and control of expression by tumor necrosis factor","volume":"14","author":"Min","year":"1986","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. 2","key":"10.1016\/j.molimm.2019.05.011_bib0410","doi-asserted-by":"crossref","first-page":"S797","DOI":"10.1016\/j.dsx.2017.06.001","article-title":"An increase level of acylation stimulating protein is correlated with metabolic risk markers in North Indian obese women","volume":"11","author":"Mishra","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.molimm.2019.05.011_bib0415","article-title":"Association of acylation stimulating protein and adiponectin with metabolic risk marker in North Indian obese women","author":"Mishra","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.molimm.2019.05.011_bib0420","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0425","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","author":"Misra","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00000441-188507000-00006","article-title":"Singular case of absence of adipose matter in the upper half of the body","volume":"90","author":"Mitchell","year":"1885","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.molimm.2019.05.011_bib0435","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","article-title":"Life without white fat: a transgenic mouse","volume":"12","author":"Moitra","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.molimm.2019.05.011_bib0440","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fendo.2018.00458","article-title":"Homozygous and heterozygous nuclear lamin a p.R582C mutation: different lipodystrophic phenotypes in the same kindred","volume":"9","author":"Montenegro","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0445","first-page":"443","article-title":"Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity","volume":"20","author":"Moulds","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0450","doi-asserted-by":"crossref","first-page":"e46883","DOI":"10.1371\/journal.pone.0046883","article-title":"Recombinant acylation stimulating protein administration to C3\u2212\/\u2212 mice increases insulin resistance via adipocyte inflammatory mechanisms","volume":"7","author":"Munkonda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.05.011_bib0455","first-page":"548","article-title":"Complement activation in chronic liver disease","volume":"47","author":"Munoz","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0460","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/endo.141.3.7364","article-title":"Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein","volume":"141","author":"Murray","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.molimm.2019.05.011_bib0465","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.metabol.2004.08.021","article-title":"The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients","volume":"54","author":"Musso","year":"2005","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.molimm.2019.05.011_bib0470","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2370.1998.00110.x","article-title":"Complement C4B null allele status confers risk for systemic lupus erythematosus in a Spanish population","volume":"25","author":"Naves","year":"1998","journal-title":"Eur. J. Immunogenet."},{"key":"10.1016\/j.molimm.2019.05.011_bib0475","article-title":"Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy","author":"Noris","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0480","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13104-016-1975-9","article-title":"Barraquer-Simons syndrome: a rare form of acquired lipodystrophy","volume":"9","author":"Oliveira","year":"2016","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.molimm.2019.05.011_bib0485","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1021827520301","article-title":"Lipoatrophic diabetes and other related syndromes","volume":"4","author":"Oral","year":"2003","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.molimm.2019.05.011_bib0490","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-019-01862-8","article-title":"Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy","author":"Oral","year":"2019","journal-title":"Endocrine."},{"key":"10.1016\/j.molimm.2019.05.011_bib0495","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jc.2005-1220","article-title":"Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy","volume":"91","author":"Oral","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0500","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1210\/jcem.87.7.8591","article-title":"Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy","volume":"87","author":"Oral","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0505","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.05.011_bib0510","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/07435800.2018.1513029","article-title":"A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities","volume":"44","author":"Ozgen Saydam","year":"2019","journal-title":"Endocr. Res."},{"key":"10.1016\/j.molimm.2019.05.011_bib0515","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6793-10-4","article-title":"The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice","volume":"10","author":"Paglialunga","year":"2010","journal-title":"BMC Physiol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0520","doi-asserted-by":"crossref","first-page":"E521","DOI":"10.1152\/ajpendo.00590.2007","article-title":"Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice","volume":"294","author":"Paglialunga","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0525","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/jc.2015-2476","article-title":"A Novel Syndrome of Generalized Lipodystrophy Associated With Pilocytic Astrocytoma","volume":"100","author":"Patni","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0530","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molimm.2008.09.013","article-title":"Dual role of complement in adipose tissue","volume":"46","author":"Pattrick","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0535","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.05.011_bib0540","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1073\/pnas.86.19.7490","article-title":"Obesity-linked regulation of the adipsin gene promoter in transgenic mice","volume":"86","author":"Platt","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.05.011_bib0545","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00128071-200708010-00003","article-title":"Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs","volume":"8","author":"Radermecker","year":"2007","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0550","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/AOG.0b013e318297e98f","article-title":"Vulvar pyoderma gangrenosum originating from a healed obstetric laceration","volume":"122","author":"Reed","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0555","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/bmj.280.6230.1500","article-title":"Insulin-induced lipoatrophy: evidence for an immune pathogenesis","volume":"280","author":"Reeves","year":"1980","journal-title":"Br. Med. J."},{"issue":"Suppl. 4","key":"10.1016\/j.molimm.2019.05.011_bib0560","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.ijo.0801493","article-title":"A-ZIP\/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes","volume":"24","author":"Reitman","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.molimm.2019.05.011_bib0565","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2013.02.007","article-title":"The liver diseases of lipodystrophy: the long-term effect of leptin treatment","volume":"59","author":"Safar Zadeh","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0570","first-page":"342802","article-title":"Plasma levels of acylation-stimulating protein are strongly predicted by Waist\/Hip ratio and correlate with decreased LDL size in men","volume":"2013","author":"Saleh","year":"2013","journal-title":"ISRN Obes."},{"key":"10.1016\/j.molimm.2019.05.011_bib0575","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1242\/dmm.002907","article-title":"Mouse models of inherited lipodystrophy","volume":"2","author":"Savage","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.molimm.2019.05.011_bib0580","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalities in acquired lipodystrophy revisited","volume":"94","author":"Savage","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molimm.2019.05.011_bib0585","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00125-018-4777-x","article-title":"The many secret lives of adipocytes: implications for diabetes","volume":"62","author":"Scherer","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.molimm.2019.05.011_bib0590","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2337\/db15-1550","article-title":"Leptin substitution in patients with lipodystrophy: neural correlates for long-term success in the normalization of eating behavior","volume":"65","author":"Schl\u00f6gl","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2019.05.011_bib0595","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/0016-5085(93)90359-K","article-title":"Early-onset autoimmune hepatitis is associated with a C4A gene deletion","volume":"104","author":"Scully","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molimm.2019.05.011_bib0600","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2249.1992.tb03011.x","article-title":"Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE)","volume":"87","author":"Segurado","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0605","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.1840090238","article-title":"C4 function in children with autoimmune chronic active hepatitis","volume":"9","author":"Senaldi","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.molimm.2019.05.011_bib0610","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2019.05.011_bib0615","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM197602262940902","article-title":"The complement abnormalities of lipodystrophy","volume":"294","author":"Sissons","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.05.011_bib0620","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjms.2016.05.007","article-title":"Barraquer-simons syndrome","volume":"352","author":"Small","year":"2016","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.molimm.2019.05.011_bib0625","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","article-title":"Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C","volume":"66","author":"Speckman","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molimm.2019.05.011_bib0630","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.164.3878.436","article-title":"Serum C\u20193 lytic system in patients with glomerulonephritis","volume":"164","author":"Spitzer","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.05.011_bib0635","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-0004.1990.tb03608.x","article-title":"Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population","volume":"38","author":"Sturfelt","year":"1990","journal-title":"Clin. Genet."},{"key":"10.1016\/j.molimm.2019.05.011_bib0640","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2018.06.264","article-title":"New tricks for an ancient system: physiological and pathological roles of complement in the CNS","volume":"102","author":"Tenner","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0645","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(73)92516-6","article-title":"Partial lipodystrophy and hypocomplementaemic nephritis","volume":"2","author":"Thompson","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2019.05.011_bib0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2012","article-title":"Hypoxia and adipose tissue function and dysfunction in obesity","volume":"93","author":"Trayhurn","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molimm.2019.05.011_bib0655","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ando.2012.04.010","article-title":"How to diagnose a lipodystrophy syndrome","volume":"73","author":"Vantyghem","year":"2012","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0660","article-title":"Abnormal lipid storage related to adipocyte shrinkage in acquired partial lipodystrophy (Barraquer-Simons syndrome)","author":"Velter","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0665","first-page":"119","article-title":"Autoimmune hepatitis","volume":"11","author":"Vergani","year":"1996","journal-title":"Ann. Ital. Med. Int."},{"key":"10.1016\/j.molimm.2019.05.011_bib0670","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(85)90348-4","article-title":"Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis","volume":"2","author":"Vergani","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2019.05.011_bib0675","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","article-title":"Adiponectin, the past two decades","volume":"8","author":"Wang","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0680","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1016\/S0021-9258(19)50409-4","article-title":"Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue","volume":"267","author":"White","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.05.011_bib0685","first-page":"591","article-title":"Hypocomplementaemic membranoproliferative glomerulonephritis and nephrotic syndrome associated with partial lipodystrophy of the face and trunk","volume":"65","author":"Williams","year":"1972","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.molimm.2019.05.011_bib0690","first-page":"577","article-title":"Complement C4 levels in SLE in relation to null allele status","volume":"21","author":"Wilson","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0695","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00281-017-0663-8","article-title":"Diseases of complement dysregulation-an overview","volume":"40","author":"Wong","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0700","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/jcb.23076","article-title":"The molecular mechanism of acylation stimulating protein regulation of adipophilin and perilipin expression: involvement of phosphoinositide 3-kinase and phospholipase C","volume":"112","author":"Wu","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molimm.2019.05.011_bib0705","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.4049\/jimmunol.1701668","article-title":"Contribution of adipose-derived factor D\/Adipsin to complement alternative pathway activation: lessons from lipodystrophy","volume":"200","author":"Wu","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0710","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0026-0495(03)00254-3","article-title":"Acylation-stimulating protein precursor proteins in adipose tissue in human obesity","volume":"52","author":"Xia","year":"2003","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.molimm.2019.05.011_bib0715","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.molimm.2019.05.011_bib0720","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000075689","article-title":"The intricate role of complement component C4 in human systemic lupus erythematosus","volume":"7","author":"Yang","year":"2004","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.molimm.2019.05.011_bib0725","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.4049\/jimmunol.173.4.2803","article-title":"Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus","volume":"173","author":"Yang","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.05.011_bib0730","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.ijo.0803173","article-title":"Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes","volume":"30","author":"Yang","year":"2006","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0735","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF02536592","article-title":"Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue","volume":"26","author":"Yasruel","year":"1991","journal-title":"Lipids"},{"key":"10.1016\/j.molimm.2019.05.011_bib0740","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1743-7075-3-13","article-title":"Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects","volume":"3","author":"Yu","year":"2006","journal-title":"Nutr. Metab. (Lond)"},{"key":"10.1016\/j.molimm.2019.05.011_bib0745","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019302330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019302330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:32:05Z","timestamp":1758979925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589019302330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":149,"alternative-id":["S0161589019302330"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.05.011","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of lipodystrophy and the role of the complement system","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}